Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Learn what's the best investment strategy to help you maximize your returns and achieve your financial goals.
22,631 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
XRP’s on-exchange stock fell to a seven-year low while the price stayed rangebound. Analysts cite ETF custody moves a...
Ultra-wealth households are paying premium to private staff amid a tightening labor market, with some packages includ...
A 61-year-old worker loses her job and learns the Social Security estimate may be overstated because of a hidden assu...
As AI investment surges, the real cash flow winners are the hardware and infrastructure suppliers. Analysts say forge...
When two tech giants sit in the same valuation neighborhood, smart investors focus on the details. This guide breaks ...
A joint U.S.-Russian crew has arrived at the ISS, signaling continued cooperation in orbit even as global tensions pe...
Solana's SOL token flashed a buy signal, signaling a potential rally. Analysts see targets near $96 and $120 if momen...
Alphabet faces a pivotal year as AI monetization expands and cloud momentum compounds. Traders watch how capital spen...
A high-value delivery went missing from a FedEx facility, valued at nearly $241k. The coins later showed up in pawn s...
A nationwide lettuce recall disrupts menus and weighs on restaurant margins. Investors watch producers and chains as ...
Rising RMDs in 2026 are narrowing the window to convert Traditional 401(k) funds to a RO TH IRA. Tax implications and...